Regulation of Nek6 Functions by Its SUMOylation on the |
Lee, Eun-Jeoung
(School of Science Education, Chungbuk National University)
Hyun, Sung-Hee (Department of Pre-medicine, Eulji University School of Medicine) Chun, Jae-Sun (Department of Biology Education, Korea National University of Education) Shin, Sung-Hwa (School of Science Education, Chungbuk National University) Lee, Kyung-Eun (School of Science Education, Chungbuk National University) Park, In-Suk (School of Science Education, Chungbuk National University) Kang, Sang-Sun (School of Science Education, Chungbuk National University) |
1 | Belham C, Comb MJ and Avruch J (2001) Identification of the NIMA family kinases NEK6/7 as regulators of the p70 ribosomal S6 kinase. Curr BioI 11: 1155-1167 DOI ScienceOn |
2 | Bohren KM, Nadkami V, Song JR, Gabbay KH and Owerbach D (2004) A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J BioI Chem 279: 27233-27238 DOI ScienceOn |
3 | Gill G (2004) SUMO and ubiquitin in the nucleus: different fimctions, similar mechanisms?. Genes Dev 18: 2046-2059 DOI ScienceOn |
4 | Kikuchi A, Kishida S and Yamamoto H (2006) Regulation of Wnt signaling by protein-protein interaction and post-translational modifications. Exp Mol Med 38: 1-10 DOI |
5 | Minoguchi S, Minoguchi M and Yoshimura A (2003) Differential control of the NIMA-related kinases, Nek6 and Nek7, by serum stimulation. Biochem Biophys Res Cornrnun 301: 899-906 DOI ScienceOn |
6 | Roig J, Mikhailov A, Belham C, and Avruch J (2002) Nerccl, a mammalian NIMA-family kinase, binds the Ran GTPase and regulates mitotic progression. Genes Dev 16: 1640-1658 DOI ScienceOn |
7 | Kandli M, Feige E, Chen A, Kilfm G and Motro B (2000) Isolation and characterization of two evolutionarily conserved murine kinases (Nek6 and nek7) related to the fungal mitotic regulator, NIMA. Genomics 68: 187-196 DOI ScienceOn |
8 | Malumbres M and Barbacid M (2007) Cell cycle kinases in cancer. Curr Opin Genet Dev 17: 60-65 DOI ScienceOn |
9 | Belham C, Roig J, Caldwell JA, Aoyama Y, Kemp BE, Comb M and Avruch J (2003) A mitotic cascade of NIMA family kinases. NercclINek9 activates the Nek6 and Nek7 kinases. J BioI Chem 278: 34897-34909 DOI ScienceOn |
10 | van Waardenburg RC, Duda DM, Lancaster CS, Schulman BA and Bjornsti MA (2006) Distinct functional domains of Ubc9 dictate cell survival and resistance to genotoxic stress. Mol Cell BioI 26: 4958-4969 DOI ScienceOn |
11 | Lizcano JM, Deak M, Morrice N, Kieloch A, Hastie CJ, Dong L, Schutkowski M, Reimer U and Alessi DR (2002) Molecular basis for the substrate specificity of NIMA-related kinase-6 (NEK6). Evidence that NEK6 does not phosphorylate the hydrophobic motif of ribosomal S6 protein kinase and serum-and glucocorticoid-induced protein kinase in vivo. J BioI Chem 277: 27839-27849 DOI ScienceOn |
12 | Hashimoto Y, Akita H, Hibino M, Kohri K and Nakanishi M (2002) Identification and characterization of Nek6 protein kinase, a potential human homolog of NIMA histone H3 kinase. Biochem Biophys Res Commun 293: 753-758 DOI ScienceOn |
13 | Quannby LM and Mahjoub MR (2005) Caught Nek-ing: cilia and centrioles. J Cell Sci 118: 5161-5169 DOI ScienceOn |
14 | Hietakangas V, Anckar J, Blomster HA, Fujimoto M, Palvimo JJ, Nakai A and Sistonen L (2006) PDSM, a motif for SUMOylation-dependent SUMO modification. Proc Natl Acad Sci USA 103: 45-50 |
15 | Zhang H., Saitoh Hand Matunis MJ (2002) Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex. Mol Cell BioI 22: 6498-6508 DOI ScienceOn |
16 | Boggio R, Colombo R, Hay RT, Draetta GF and Chiocca S (2004) A mechanism for inhibiting the SUMO pathway. Mol Cell 16: 549-561 DOI ScienceOn |
17 | Duprez E, Saurin AJ, Desterro JM, Lallemand-Breitenbach V, Howe K, Boddy MN, Solomon E, de The H, Hay RT and Freemont PS (1999) SUMO-l modification of the acute promyelocytic leukemia protein PML: implications for nuclear localization. J Cell Sci 112: 381-393 |
18 | Melchior F and Hengst L (2002) SUMO-1 and p53. Cell Cycle 1: 245-249 |
19 | Dorval V and Fraser PE (2006) Small ubiquitin-like modifier (SUMO) modification ofnatlvely unfolded proteins Tau and alpha-synuclein. J BioI Chem 281: 9919-9924 DOI ScienceOn |
20 | Yin MJ, Shao L, Voehringer D, Smeal T and Jallal B (2003) The serine/threonine kinase Nek6 is required for cell cycle progression through mitosis. J BioI Chem 278: 52454-52460 DOI ScienceOn |
21 | Vega FM, Sevilla A and Lazo PA (2004) p53 Stabilization and Accumulation Induced by Human Vaccinia-Related Kinase 1. Mol Cell BioI 24: 10366-10380 DOI ScienceOn |
22 | Wilson VG and Rangasamy D (2001) Intracellular targeting of proteins by sumoylation. Exp Cell Res 271: 57-65 DOI ScienceOn |
23 | Sampson DA, Wang M and Matunis MJ (2001) The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J BioI Chem 276: 23164-23169 |
24 | Bischof O, Schwamborn K, Martin N, Werner A, Sustmann C, Grosschedl R and Dejean A (2006) The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis. Mol Cell 22: 783-794 DOI ScienceOn |
25 | Pichler A, Gast A, Seeler JS, Dejean A and Melchior F (2002) The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108: 109-120 DOI ScienceOn |
26 | Kagey MH, Melhuish TA and Wotton D (2003) The polycomb protein Pc2 is a SUMO E3. Cell 113: 127-137 DOI ScienceOn |
27 | Yang SH, Galanis A, Witty J and Sharrocks AD (2006) An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J 25: 5083-5093 DOI ScienceOn |
![]() |